Literature DB >> 1533235

Paecilomyces lilacinus infection in a child with chronic granulomatous disease.

C C Silliman1, D W Lawellin, J A Lohr, B M Rodgers, L G Donowitz.   

Abstract

Chronic granulomatous disease (CGD) is a rare inherited disorder in which neutrophils do not appropriately generate cytotoxic superoxide anion, the respiratory burst, in response to invading bacteria or fungi as a part of normal host defence. We report the case of a child with CGD who had two abdominal wall abscesses caused by Paecilomyces lilacinus, an organism not previously known to cause infections in patients with CGD. The abdominal wall is a location that is rarely associated with Paecilomyces infections. Parenteral amphotericin B eradicated the infection in an immunocompromised child whereas this regimen has heretofore largely been unsuccessful in the treatment of this infection. Paecilomyces species and other fungi from immunocompromised hosts and thought to be laboratory contaminants, need to be carefully investigated for they may become pathogens in this clinical setting.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1533235     DOI: 10.1016/0163-4453(92)92980-w

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  12 in total

1.  Multifocal osteomyelitis caused by Paecilomyces varioti in a patient with chronic granulomatous disease.

Authors:  A Cohen-Abbo; K M Edwards
Journal:  Infection       Date:  1995 Jan-Feb       Impact factor: 3.553

2.  Identification and first report of Inonotus (Phellinus) tropicalis as an etiologic agent in a patient with chronic granulomatous disease.

Authors:  D A Sutton; E H Thompson; M G Rinaldi; P C Iwen; K K Nakasone; H S Jung; H M Rosenblatt; M E Paul
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

Review 3.  Enterobacter cloacae pyomyositis complicating chronic granulomatous disease and review of gram-negative bacilli pyomyositis.

Authors:  M Gousseff; F Lanternier; A Ferroni; O Chandesris; N Mahlaoui; O Hermine; O Lortholary; M Lecuit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-02-01       Impact factor: 3.267

Review 4.  Disseminated infection due to Chrysosporium zonatum in a patient with chronic granulomatous disease and review of non-Aspergillus fungal infections in patients with this disease.

Authors:  E Roilides; L Sigler; E Bibashi; H Katsifa; N Flaris; C Panteliadis
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

Review 5.  Fungal infections in primary immunodeficiencies.

Authors:  Charalampos Antachopoulos; Thomas J Walsh; Emmanuel Roilides
Journal:  Eur J Pediatr       Date:  2007-06-06       Impact factor: 3.183

Review 6.  Complicated soft tissue infection with prepatellar bursitis caused by Paecilomyces lilacinus in an immunocompetent host: case report and review.

Authors:  F Westenfeld; W K Alston; W C Winn
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

7.  Antifungal susceptibilities of Paecilomyces species.

Authors:  C Aguilar; I Pujol; J Sala; J Guarro
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

8.  Sporothrix schenckii lymphadentitis in a male with X-linked chronic granulomatous disease.

Authors:  Jessica R Trotter; Panida Sriaroon; David Berman; Aleksandra Petrovic; Jennifer W Leiding
Journal:  J Clin Immunol       Date:  2013-11-16       Impact factor: 8.317

9.  Paecilomyces formosus Infection in an Adult Patient with Undiagnosed Chronic Granulomatous Disease.

Authors:  Jalal Heshmatnia; Majid Marjani; Seyed Alireza Mahdaviani; Parvaneh Adimi; Mihan Pourabdollah; Payam Tabarsi; Fereshte Mahdavi; Hamidreza Jamaati; Ian M Adcock; Johan Garssen; Aliakbar Velayati; Davood Mansouri; Esmaeil Mortaz
Journal:  J Clin Immunol       Date:  2017-04-20       Impact factor: 8.317

Review 10.  A Review of Chronic Granulomatous Disease.

Authors:  Danielle E Arnold; Jennifer R Heimall
Journal:  Adv Ther       Date:  2017-11-22       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.